AI entity
All 1 tracked stories fall under one category: partnership. Drug Discovery is most often covered alongside AI, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 2.6 for the same window.
Last mentioned: Feb 19, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: partnership. Drug Discovery is most often covered alongside AI, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 2.6 for the same window. Their average consequence score of 8 runs above the beat's 6.3 for that window. We currently track 1 AI story that mention Drug Discovery, all published on February 19, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 140 AI stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Drug Discovery. Shared-story counts are live from our verified record — not editorial picks.
Merck and Mayo Clinic have launched a strategic R&D collaboration to integrate artificial intelligence into drug discovery and precision medicine. The partnership combines Mayo Clinic's vast clinical data with Merck's therapeutic expertise to identify novel drug targets and personalize patient care.
Drug Discovery is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
